Ysios news
08.07.20
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
07.07.20
CVRx® Raises $50 Million in New Equity Financing
portfolio news
21.07.20
CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program
20.07.20
Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease
